INFLAMMATION AND OXIDATIVE STRESS IN EMERGING PSYCHOTIC AND MOOD DISORDERS

Grant number: 1128631 | Funding period: 2017 - 2019

Completed

Abstract

We are conducting four large clinical trials testing anti-inflammatory treatments like ?-3 PUFAs and aspirin in young people who are at high-risk for psychosis or have depression. This proposal adds an important component to this research by investigating inflammatory and oxidative stress markers. We aim to determine if the investigated biomarkers predict the course of illness and response to treatments. The findings will facilitate early intervention and targeted treatment.

University of Melbourne Researchers